NewGenIvf Group Ltd (NIVF) stock
Close on Nov 13, 2026Market cap $8.33KP/E 0.1Yield –
NewGenIvf Group Ltd grew revenue 336.3% to $23.71M over fiscal 2025. Free cash flow was -$11.06M. At the latest close the market valued the company at $8.33K, 0.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $8.33K
- P/E ratio
- 0.1
- Price to sales
- 0.00
- Price to book
- 0.00
- Dividend yield
- –
- Free cash flow yield
- -132824.00%
Fundamentals
- Revenue
- $23.71M
- Net income
- $9.88M
- EPS, diluted
- $3.04
- Free cash flow
- -$11.06M
Trading
- Previous close
- $0.28
- Open
- $0.21
- Day's range
- $0.19 – $0.24
- Volume
- 16,385,260
- Average volume (20 days)
- 1,551,768
- Beta (5 years)
- 2.87
- 52-week range
- $0.17 – $7257.82
- RSI (14 days)
- 41.8
- Volatility (1 year)
- 3687.2%
- Relative volume
- 2.35×
- WACC
- 17.6%
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NIVF | S&P 500 | Difference | NIVF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +18.3% | -3.0% | +21.4 pts | ||
| 3 months | -99.6% | -2.8% | −96.8 pts | ||
| Year to date | -100.0% | +11.5% | −111.5 pts | ||
| 1 year | -100.0% | +13.5% | −113.4 pts | ||
| 3 years | -100.0% | +77.7% | −177.7 pts | -99.9% | +21.1% |
Six years at a glance
Fiscal years 2020 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases NewGenIvf filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About NewGenIvf
Services-Misc Health & Allied Services, NEC
NewGenIvf Group Limited provides fertility and assisted reproductive technology services, assisting individuals and couples seeking fertility treatments. The company offers a suite of fertility solutions, including in vitro fertilization and pre-implantation genetic screening services. Alongside its core fertility operations, the enterprise is diversifying its business activities into digital asset management, real estate development, and mining initiatives, which include acquiring and managing cryptocurrency assets.
Company profile, executives and historyNewGenIvf stock: common questions
What is NewGenIvf's stock price?
NIVF closed at $0.23 on Nov 13, 2026, down 16.44% on the day. Over the past 52 weeks it traded between $0.17 and $7257.82.
What is NewGenIvf's market cap?
NewGenIvf was worth $8.33K at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is NIVF's P/E ratio?
NIVF trades at 0.1 times earnings, based on diluted earnings per share of $3.04 over fiscal 2025.
How much revenue does NewGenIvf make?
NewGenIvf reported revenue of $23.71M for fiscal 2025, up 336.3% from a year earlier.
Does NewGenIvf pay a dividend?
No. NewGenIvf has not paid a cash dividend over the last twelve months.
How has NIVF stock performed over the past year?
Including dividends, NIVF returned -100.0% over the past year, against +13.5% for the S&P 500.
Who are NewGenIvf's competitors?
Companies most similar to NewGenIvf by business, industry and size include CCEL, MRAI, MCTA, AGMH, EUDA.
See a number that looks wrong?